BARR ROSENBERG SERIES TRUST
NSAR-A, EX-27, 2000-11-22
Previous: BARR ROSENBERG SERIES TRUST, NSAR-A, EX-27, 2000-11-22
Next: INCUBATETHIS INC, 10QSB/A, 2000-11-22



<TABLE> <S> <C>

<ARTICLE> 6
<CIK> 0000832545
<NAME> BARR ROSENBERG SERIES TRUST
<SERIES>
   <NUMBER> 081
   <NAME> AXA ROSENBERG ENHANCED 500 FUND

<S>                              <C>
<PERIOD-TYPE>                    4-MOS
<FISCAL-YEAR-END>                                         MAR-31-2001
<PERIOD-START>                                            JUN-07-2000
<PERIOD-END>                                              SEP-30-2000
<INVESTMENTS-AT-COST>                                         4982259
<INVESTMENTS-AT-VALUE>                                        4846391
<RECEIVABLES>                                                    7239
<ASSETS-OTHER>                                                  18111
<OTHER-ITEMS-ASSETS>                                                0
<TOTAL-ASSETS>                                                4871741
<PAYABLE-FOR-SECURITIES>                                            0
<SENIOR-LONG-TERM-DEBT>                                             0
<OTHER-ITEMS-LIABILITIES>                                           0
<TOTAL-LIABILITIES>                                                 0
<SENIOR-EQUITY>                                                     0
<PAID-IN-CAPITAL-COMMON>                                      5000050
<SHARES-COMMON-STOCK>                                          500005<F1>
<SHARES-COMMON-PRIOR>                                               0<F1>
<ACCUMULATED-NII-CURRENT>                                       10091
<OVERDISTRIBUTION-NII>                                              0
<ACCUMULATED-NET-GAINS>                                             0
<OVERDISTRIBUTION-GAINS>                                         2532
<ACCUM-APPREC-OR-DEPREC>                                     (135868)
<NET-ASSETS>                                                  4871741
<DIVIDEND-INCOME>                                               16317
<INTEREST-INCOME>                                                5674
<OTHER-INCOME>                                                      0
<EXPENSES-NET>                                                  11900
<NET-INVESTMENT-INCOME>                                         10091
<REALIZED-GAINS-CURRENT>                                       (2532)
<APPREC-INCREASE-CURRENT>                                    (135868)
<NET-CHANGE-FROM-OPS>                                        (128309)
<EQUALIZATION>                                                      0
<DISTRIBUTIONS-OF-INCOME>                                           0<F1>
<DISTRIBUTIONS-OF-GAINS>                                            0<F1>
<DISTRIBUTIONS-OTHER>                                               0<F1>
<NUMBER-OF-SHARES-SOLD>                                        500005
<NUMBER-OF-SHARES-REDEEMED>                                         0
<SHARES-REINVESTED>                                                 0
<NET-CHANGE-IN-ASSETS>                                        4871741
<ACCUMULATED-NII-PRIOR>                                             0
<ACCUMULATED-GAINS-PRIOR>                                           0
<OVERDISTRIB-NII-PRIOR>                                             0
<OVERDIST-NET-GAINS-PRIOR>                                          0
<GROSS-ADVISORY-FEES>                                            7865
<INTEREST-EXPENSE>                                                  0
<GROSS-EXPENSE>                                                 24900
<AVERAGE-NET-ASSETS>                                          5035034<F1>
<PER-SHARE-NAV-BEGIN>                                           10.00<F1>
<PER-SHARE-NII>                                                  0.02<F1>
<PER-SHARE-GAIN-APPREC>                                        (0.28)<F1>
<PER-SHARE-DIVIDEND>                                             0.00<F1>
<PER-SHARE-DISTRIBUTIONS>                                        0.00<F1>
<RETURNS-OF-CAPITAL>                                             0.00<F1>
<PER-SHARE-NAV-END>                                              9.74<F1>
<EXPENSE-RATIO>                                                  0.75<F1>
<FN>
<F1> Institutional Shares
</FN>






</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission